Andrew Gengos - Chief Financial Officer at Terns Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
TERN on Nasdaq
All Insider Reports
All Insider Reports

Andrew Gengos - trading volume in the past year for Terns Pharmaceuticals, Inc.

Holdings reported by Andrew Gengos for Terns Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 25,000 $98,247 $3.93 27 Jun 2025 Direct
Stock Option (Right to Buy) 750,000 24 Feb 2025 Direct Common Stock

Transactions reported by Andrew Gengos for Terns Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.